News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

07

2023

-

06

Information | Linuo Pharmaceutical was elected as the governing unit of the Biomedical Industry Alliance in the provincial capital economic circle

Classification:

News


On June 4, the 2023 Shandong Provincial Capital Economic Circle Biomedical Industry Alliance Establishment and Biomedical Industry Collaboration Conference was held in Jinan. Zhao Yu, Director of the Consumer Goods Industry Department of Shandong Provincial Department of Industry and Information Technology, attended the meeting and delivered a speech. Zhang Jianjun, Chief Engineer of Jinan Industry and Information Technology Bureau, attended the meeting and reported on the preparations for the alliance.

11

In order to fully implement the major national strategy of ecological protection and high-quality development of the Yellow River Basin, build a modern provincial capital economic circle at a high level, promote coordinated regional development, deepen industrial division of labor and cooperation, and jointly promote the integrated development of the biomedical industry, with the support of the Provincial Department of Industry and Information Technology , Jinan, Zibo, Tai'an, Liaocheng, Dezhou, Binzhou, Dongying 7 city bureaus of industry and information technology and 11 alliance initiators jointly established an industrial alliance. The alliance conference brought together the first batch of member units, including more than 80 biopharmaceutical enterprises above designated size within the provincial capital economic circle, as well as university research institutes related to the biopharmaceutical industry, providing exchanges and mutual learning for industry departments and pharmaceutical companies, deepening The cooperation platform will greatly promote the improvement of the basic capabilities of the province's pharmaceutical industry and the modernization level of the industrial chain.

11

Linuo Pharmaceutical was invited to participate in this conference and was elected as the governing unit of the industry alliance. Linuo Pharmaceutical is committed to becoming a first-class drug manufacturer in China. The raw materials of the main products come from the parent company Keyuan Pharmaceutical (stock code 301281), and it cooperates with WuXi AppTec, Pharmaron Chemicals, Beijing Nuokangda, Beijing Sunshine Nuohe and other research and development units to carry out industry-university-research cooperation. In the future, Linuo Pharmaceutical will give full play to the advantages of the integration of raw materials and preparations, promote scientific research and innovation, protect the national economy and people's livelihood, protect the green waters and green mountains of the motherland, and contribute to the realization of the great rejuvenation of the Chinese nation.

Related news

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

2023-08-31

On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd.

Solidly promote the

Solidly promote the "Quality Month" activities to help quality work reach a new level | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a Quality Month Knowledge Competition!

2023-08-30

Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training.

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

2023-08-24

In order to thoroughly implement the theme spirit of "Quality is in my hands and customers are in my heart" for Keyuan Pharmaceutical (stock code: 301281.SZ) Quality Month in 2023, and empower and improve quality management, the Quality Management Center and Human Resources Center held a meeting on August 23 The joint organization carried out a one-day QC group activity training meeting.

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

2023-08-23

In order to better carry forward the corporate culture spirit of family, one table meal, one heart, one effort, enhance the cohesion and sense of belonging of all employees, enrich the spiritual and cultural life of employees, and let the majority of employees feel that Keyuan Pharmaceutical (stock code: 301281.SZ) The warmth of the big family.